Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of analgesic effects and side effects after different doses of hydromorphone
ChiCTR2500099256Phase 4Not yet recruiting
- Sponsor
- The Second Hospital of Nanjing
- Start
- Mar 2025
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of hydromorphone in postoperative pain (3 arms), sponsored by The Second Hospital of Nanjing. Primary endpoints: Pain visual analogue scale (VAS), Number of times of pressing of the automatic analgesic pump and 2 more. Planned start Mar 2025; status: not yet recruiting.
02
Drugs
hydromorphone
03
Conditions
postoperative pain
Beyond the preview
Go deeper on ChiCTR2500099256.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500099256.